期刊文献+

108例HIV感染者/AIDS病人临床分析 被引量:4

Clinical analysis of 108 cases with HIV/AIDS
下载PDF
导出
摘要 目的了解艾滋病重点村艾滋病病毒(H IV)感染者和获得性免疫缺陷综合征(AIDS)临床表现的特点,及抗逆转录病毒治疗(ART)的效果。方法对H IV感染者和AIDS病人的流行病学和临床资料加以归纳总结。结果AIDS病人72例。28例进行了丙肝抗体检测,仅1例阴性。69例AIDS病人进行了抗逆转录病毒治疗,服药后34例患者出现了不同程度的不良反应,16例退出治疗,50例AIDS病人坚持抗病毒治疗半年至1年半临床症状改善率94%结论ART确实大大减轻了患者的临床症状,但不良反应较大,影响了患者的服药依从性,部分病人出现耐药,药物的组合和选择均受到限制,探索适合贫困地区抗逆转录病毒治疗的新路已是当务之急。 Aim To understand clinical characteristic of HIV/AIDS in one AIDS village in Fuyang,and determine the effect of the ART (antiretroviral therapy). Methods Analysis the epidemiological and clinical of 108 cases with HIV/AIDS. Results 69 AIDS cases were treated with ART. Side effects were found in 34 cases. 16 cases stopped treatment on the half way. 50 cases persisted in treatment. Clinical symptoms were well improved (94%) ,CD4 cell counts were risen (66%) ,and HIV viral loads were descended l0 times and undeteetable (62%). 16 cases had resistance. Conclusion It is very important to protect the high risk groups and intervene in high risk behavior. ART (antiretroviral therapy) is the most effective method in curing HIV/AIDS, and its clinical effectiveness is closely related to the clinical compliance.
出处 《安徽医药》 CAS 2005年第12期920-922,共3页 Anhui Medical and Pharmaceutical Journal
  • 相关文献

参考文献2

二级参考文献29

  • 1Perez-Elias MJ,Lanier R,Munoz V,et al. Phenotypic testing predicts virological response in successive protease inhibitor-based regimens[J]. AIDS, 2000,14:F95-F101.
  • 2Coffin J M. HIV population dynamics in vivo:implications for genetic variation,pathogenesis and therapy[J]. Science,1995,267: 483-489.
  • 3De Gruttola V,Dix L,D'Aquila R,et al. The relation between baseline HIV drug resistance and response to antiretroviral therapy:reanalysis of retrospective and prospective studies using a standardized data analysis plan[J]. Antiviral Ther,2000,5:41-48.
  • 4Palmer S,Shafer RW,Merigan TC. Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development[J]. AIDS, 1999, 13:661-667.
  • 5Robert L. Murphy. New antiretroviral drug in development[J]. AIDS, 2000,14(suppl 3):S227-S234.
  • 6Menendez-Arias,L. Molecular basis of fidelity of DNA synthesis and nucleotide specificity of retroviral reverse transcriptases[J]. Progr Nucleic Acid Res Mol Biol, 2002, 71: 91-147.
  • 7Havlir DV,Richman DD. Viral dynamics of HIV:implications for drug development and therapeutic strategies[J]. Ann Intern Med, 1996, 124:984-994.
  • 8Miller V,Ait-Khaled M,Stone C,et al. HIV-1 reverse transcriptase(RT)genotype and susceptibility to PT inhibitors during abacavir monotherapy and combination therapy[J]. AIDS, 2000, 14:163-171.
  • 9Petropoulos CJ,Parkin NT,Limoli KL,et al. A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1 [J]. Antimicrob Agents Chemotherap, 2000, 44:92928.
  • 10Montaner JS,Hogg R,Raboud J,et al. Antiretroviral treatment in 1998[J]. Lancet, 1998,352:1919-1922.

共引文献81

同被引文献75

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部